[1] |
Cooper DS, Laurberg P. Hyperthyroidism in pregnancy[J]. Lancet Diabetes Endocrinol,2013,1(3):238-249.
|
[2] |
Greenhill C. Obesity: gut microbiome and serum metabolome changes[J]. Nat Rev Endocrinol,2017,13(9):501.
|
[3] |
Laurberg P, Andersen SL, Hindersson P, et al. Dynamics and predictors of serum TSH and FT4 reference limits in early pregnancy: a study within the Danish national birth cohort[J]. J Clin Endocrinol Metab.2016,101(6):2484-2492.
|
[4] |
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J]. Thyroid,2011,21(10):1081-1125.
|
[5] |
Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J]. Thyroid,2017,27(3):315-389.
|
[6] |
ACOG. Thyroid disease in pregnancy: ACOG practice bulletin, number 223[J]. Obstet Gynecol,2020,135(6):e261-274.
|
[7] |
《妊娠和产后甲状腺疾病诊治指南》(第2版)编撰委员会,中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南(第2版)[J].中华内分泌代谢杂志,2019,35(8):636-665.
|
[8] |
Dong AC, Stagnaro-Green A. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: a systematic review and meta-analysis[J]. Thyroid,2019,29(2):278-289.
|
[9] |
Laurberg P, Andersen SL. Endocrinology in pregnancy: pregnancy and the incidence, diagnosing and therapy of Graves′ disease[J]. Eur J Endocrinol,2016,175(5):R219-230.
|
[10] |
Kinomoto-Kondo S, Umehara N, Sato S, et al. The effects of gestational transient thyrotoxicosis on the perinatal outcomes: a case-control study[J]. Arch Gynecol Obstet,2017,295(1):87-93.
|
[11] |
Guo N, Xue M, Liang Z. Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves′ disease[J]. Arch Gynecol Obstet,2023,308(2):403-411.
|
[12] |
Turunen S, Vääräsmäki M, Lahesmaa-Korpinen AM, et al. Maternal hyperthyroidism and pregnancy outcomes: a population-based cohort study[J]. Clin Endocrinol,2020,93(6):721-728.
|
[13] |
Andersen SL, Andersen S, Vestergaard P, et al. Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: a Danish nationwide case-cohort study[J]. Thyroid,2018,28(4):537-546.
|
[14] |
Liu Y, Li Q, Xu Y, et al. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: a systematic review and meta-analysis[J]. PloS One,2023,18(5):1-13.
|
[15] |
Kuy S, Roman SA, Desai R, et al. Outcomes following thyroid and parathyroid surgery in pregnant women[J]. Arch Surg,2009,144(5):399-406.
|
[16] |
Erbil Y, Ozluk Y, Giris M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves′ disease[J]. J Clin Endocrinol Metab,2007,92(6):2182-2189.
|
[17] |
Yoshihara A, Noh JY, Watanabe N, et al. Substituting potassium iodide for methimazole as the treatment for Graves′ disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan[J]. Thyroid,2015,25(10):1155-1161.
|
[18] |
Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation[J]. Eur J Endocrinol, 2011,164(6):871-876.
|
[19] |
Gudala K, Bansal D, Kandikatla LR, et al. PRM12-Thyroid dysfunction detection in pregnancy: universal screening or targeted high-risk case finding? A meta-analysis[J]. Value in Health,2013,16(7):A701.
|
[20] |
《孕产期甲状腺疾病防治管理指南》编撰委员会,中华医学会内分泌学分会,中华预防医学会妇女保健分会. 孕产期甲状腺疾病防治管理指南[J]. 中华内分泌代谢杂志,2022,38(7):539-551.
|
[21] |
Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves′ disease after a successful course of antithyroid drug therapy[J]. J Clin Endocrinol Metab,2008,93(10):3985-3988.
|
[22] |
Azizi F, Khoshniat M, Bahrainian M, et al. Thyroid function and intellectual development of infants nursed by mothers taking methimazole[J]. J Clin Endocrinol Metab,2000,85(9):3233-3238.
|
[23] |
Momotani N, Yamashita R, Makino F, et al. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil[J]. Clin Endocrinol,2000,53(2):177-181.
|